Skip to main content

Transplant

Transplant Research Institute

Clinical Trials

Showing 1-9 out of 9 results.
NCT04849728

'Inventiva S.A. / “A randomised, double-blind, placebo- controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage of liver fibrosis”
'

Icon for trial | 337HNAS20011 'Inventiva S.A. / “A randomised, double-blind, placebo- controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and f

This study is currently enrolling.

Inventiva S.A. (the Sponsor) is running a research study to see if an investigational drug named lanifibranor, not yet approved for marketing, will help in the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) and ...

NCT04471909

TRIOMPHE - A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch

Icon for trial | CIP009 TRIOMPHE - A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch

This study is currently enrolling.

This study involves research. The purpose of this research study is to continue to test how well the Endospan NEXUS Aortic Arch Stent Graft System performs in the treatment of a diseased aortic arch. The aortic arch is the top ...

NCT04464785

CentriMag Failure-to-Wean Post Approval Study

Icon for trial | ABT-CIP-10336 CentriMag Failure-to-Wean Post Approval Study

You are being invited by your doctor to take part in this research study evaluating the post-market performance of the FDA-approved CentriMag Circulatory Support System because your doctor has determined that this device could ...

NCT05258942

MyLeukoMAP Genomic Survival Prediction Assay

Icon for trial | LLDX1012021 MyLeukoMAP Genomic Survival Prediction Assay

Heart failure (HF) can cause other organs to shut down. This process appears to involve the white blood cells of the immune system. Our data show that abnormal gene activation or suppression of white blood cells may be indicati ...